The
medical report “Autoimmune Disease
Diagnostics Market Size By Product [Systemic
(Rheumatoid Arthritis, Ankylosing Spondylitis, Systemic Lupus Erythematosus
(SLE)), Localized], Industry Analysis Report, Regional Outlook (U.S., Canada,
Germany, U.K, Japan, China, Brazil) Application Potential, Price Trends,
Competitive Market Share & Forecast, 2016 – 2023”, by Global Market
Insights, Inc. says the global
autoimmune disease diagnostics market worth USD 12.8 billion in 2015, is
anticipated to grow at a moderate CAGR of 2.5%, hitting USD 15 billion in 2023.
Autoimmune disease diagnostics market is revolutionizing
the healthcare industry due to alarming rates of autoimmune diseases globally.
Autoimmune diseases are self-inflicted diseases caused due to the abnormal
immune response to a body part. As per the NIH Autoimmune Disease Coordinating
Committee (ADCC), 14-22 million people in the U.S. are affected by some sort of
autoimmune diseases. Another study depicts 7 million people in the Europe to be
suffering from autoimmune ailments. Moreover, NIH (National Institutes of
Health) mentions autoimmune diseases to be one of the top 10 causes of female
demise in the U.S.
The
issue has been a matter of serious concern worldwide and is being addressed by
measurements taken at individual and government levels. Growing prevalence of these diseases,
rising awareness among patients, and government initiatives towards reducing
the frequency of such ailments will be the major factors driving the market
growth over the next eight years, as per the report.
The
frequent occurrence of these diseases has resulted in a huge healthcare expenditure.
The treatment of autoimmune ailments is way costlier and is a serious concern
to the overall healthcare system. For instance, annual medical expenditure for
the treatment of multiple sclerosis (a type of autoimmune disease) comes to
approximately USD 2.5 billion, a cost higher than that incurred during diabetes
treatment.
Government
measures addressing this global issue is favorably impacting the growth of new
diagnostic methods to detect and cure such ailments, in turn favoring the
global autoimmune disease diagnostics market. The month of March has been
designated as the “National Autoimmune Disease Awareness Month.” Another
remarkable development in the field of autoimmune disease diagnostics is the
formation of Autoimmunity Centers of Excellence (ACE) by the collaboration of
NIH, non-profit organizations, and pharmaceutical companies which performs
various researches for the development of diagnostic tools.
Browse key industry insights spread across 82 pages with 30
market data tables & 28 figures & charts from the report Autoimmune Disease Diagnostics Market in detail along with
the table of contents:
The U.S will
be leading the North America autoimmune disease diagnostics market due to the
high occurrence of related ailments accompanied by rising patient awareness in
this region. The market is estimated to reach USD 3.5 billion by 2023. North
America will be dominating the global market over the coming years.
Europe
market is set to secure the second position globally driven by the government
support in these regions. Germany and UK will drive the regional growth.
The Asia
Pacific, on account of its large patient pool, is pegged to grow at a CAGR of
5.3% over the period of 2016-2023.
On the
product front, the localized autoimmune disease diagnostics will dominate the
systematic diagnostics segment over the coming period. The localized autoimmune
disease diagnostics market is likely to surpass USD 10 billion by 2023.
The industry
is fragmented and is being influenced by the ongoing trends of diagnostics
industry such as developments in genetic testing, rise in the personalized
medicine industry, focus towards prevention rather than treatment, etc. The
players are making huge investments in the R&D and their respective product
innovations to meet the growing technological demands. Major industry
participants are Siemens Healthineers, Roche Diagnostics, Euroimmun, Abbott
Laboratories, Beckman Coulter Inc., Quest Diagnostics, SQI Diagnostics Inc, and
INOVA Diagnostics, Inc.
Table of Contents
Chapter 1.
Methodology and Scope
1.1.
Research
Methodology
1.1.1. Initial data exploration
1.1.2. Statistical modeling and
forecast
1.1.3. Industry insights and
validation
1.2. List of
Data Sources
Chapter 2.
Executive Summary
2.1.
Autoimmune Disease Diagnostics industry 3600 synopsis, 2012 - 2023
2.1.1. Business trends
2.1.2. Regional trends
2.1.3. Application trends
Chapter 3. Autoimmune
Disease Diagnostics Industry Insights
3.1.
Industry segmentation
3.2.
Industry size and future growth prospects, 2012 - 2023
3.3.
Industry dynamics
3.3.1. Growth drivers
3.3.1.1. Increasing funding for research
3.3.1.2. Favorable government initiatives
3.3.1.3. Rising patient awareness levels
3.3.1.4. Increasing adoption of lab automation
technology
3.3.2. Industry pitfalls &
challenges
3.3.2.1. Long turnaround time of diagnostic tests and
lack of skilled technicians
3.4. Key
growth opportunities
3.5.
Porter’s analysis
3.6. PESTEL
analysis
Browse Related Reports:
Molecular Diagnostics Market
Size By Infectious Disease (Flu, Tuberculosis,
Meningitis, RSV Virus, Hepatitis B, Hepatitis C, HPV, STD, HIV, Dengue,
Gonorrhea, Chlamydia, TORCH, H. Pylori), By Technology (PCR, Real-Time PCR,
DNA/RNA Purification), Industry Analysis Report, Regional Outlook (U.S.,
Canada, Germany, UK, France, Spain, Portugal, Italy, Russia, Denmark, Norway,
Sweden, Israel, Japan, China, India, Sri Lanka, Pakistan, Philippines, South
Korea, Australia, New Zealand, Vietnam, Thailand, Mexico, Brazil, Argentina,
Colombia, Chile, Peru, South Africa, Nigeria, Morocco, Egypt, KSA, UAE, Jordan,
Qatar), Application Potential, Price Trend, Competitive Market Share &
Forecast, 2016 – 2023
About Global Market Insights:
Global Market
Insights, Inc., headquartered in Delaware, U.S., is a global market research
and consulting service provider; offering syndicated and custom research
reports along with growth consulting services. Our business intelligence and
industry research reports offer clients with penetrative insights and
actionable market data specially designed and presented to aid strategic
decision making. These exhaustive reports are designed via a proprietary
research methodology and are available for key industries such as chemicals,
advanced materials, technology, renewable energy and biotechnology.
Contact Us:
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com
Web: https://www.gminsights.com
Blog: https://gminsights.wordpress.com
Connect with us: Facebook | Google+ | LinkedIn | Twitter
No comments:
Post a Comment